S. Tompkins

R. Tripp, S. Tompkins, N. Pollock, 2013, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Identification of Host Kinase Genes Required for Influenza Virus Replication and the Regulatory Role of MicroRNAs

R. Tripp, D. Jin, Victoria A. Meliopoulos, 2013, PloS one.

Memory T Cells Generated by Prior Exposure to Influenza Cross React with the Novel H7N9 Influenza Virus and Confer Protective Heterosubtypic Immunity

R. Compans, R. Tripp, S. Tompkins, 2015, PloS one.

Vaccination with Recombinant Parainfluenza Virus 5 Expressing Neuraminidase Protects against Homologous and Heterologous Influenza Virus Challenge

R. Tripp, S. Tompkins, B. He, 2017, Journal of Virology.

Sialic acid-containing glycolipids mediate binding and viral entry of SARS-CoV-2

S. Hsu, T. Hobman, Matthew S Macauley, 2021, Nature Chemical Biology.

Sialic acid-Dependent Binding and Viral Entry of SARS-CoV-2

S. Hsu, Matthew S Macauley, G. Boons, 2021, bioRxiv.

Indoleamine 2,3-dioxygenase (IDO) activity during the primary immune response to influenza infection modifies the memory T cell response to influenza challenge.

R. Tripp, S. Tompkins, A. Mellor, 2014, Viral immunology.

Domestic Cats Are Susceptible to Infection With Low Pathogenic Avian Influenza Viruses From Shorebirds

D. Stallknecht, S. Tompkins, R. Berghaus, 2013, Veterinary pathology.

An insulin peptide that binds an alternative site in class II major histocompatibility complex

S. Tompkins, P. Jensen, J. Moore, 1996, The Journal of experimental medicine.

Verdinexor, a Novel Selective Inhibitor of Nuclear Export, Reduces Influenza A Virus Replication In Vitro and In Vivo

E. Baloglu, R. Tripp, S. Tompkins, 2014, Journal of Virology.

Virus-Vectored Influenza Virus Vaccines

R. Tripp, S. Tompkins, 2014, Viruses.

Induction and Role of Indoleamine 2,3 Dioxygenase in Mouse Models of Influenza A Virus Infection

R. Tripp, S. Tompkins, A. Mellor, 2013, PloS one.

Aerosol vaccination induces robust protective immunity to homologous and heterologous influenza infection in mice.

Raydel D. Mair, R. Tripp, S. Tompkins, 2011, Vaccine.

Nebulized live-attenuated influenza vaccine provides protection in ferrets at a reduced dose.

Raydel D. Mair, R. Tripp, S. Tompkins, 2012, Vaccine.

Evaluation of a New Viral Vaccine Vector in Mice and Rhesus Macaques: J Paramyxovirus Expressing Hemagglutinin of Influenza A Virus H5N1

S. Tompkins, B. He, F. Villinger, 2021, Journal of virology.

Moving Forward: Recent Developments for the Ferret Biomedical Research Model

P. Thomas, R. Albrecht, S. Schultz-Cherry, 2018, mBio.

IN OVO AND IN VITRO SUSCEPTIBILITY OF AMERICAN ALLIGATORS (ALLIGATOR MISSISSIPPIENSIS) TO AVIAN INFLUENZA VIRUS INFECTION

T. Glenn, S. Tompkins, J. Gabbard, 2015, Journal of wildlife diseases.

SARS-CoV-2 spike protein binds heparan sulfate in a length- and sequence-dependent manner

M. Wolfert, G. Boons, S. Tompkins, 2020, bioRxiv.

SARS-CoV-2 spike protein binds heparan sulfate in a length- and sequence-dependent manner

M. Wolfert, G. Boons, S. Tompkins, 2020, bioRxiv.

A flexible, pan-species, multi-antigen platform for the detection and monitoring of SARS-CoV-2-specific antibody responses

N. Rouphael, L. Wells, K. Moremen, 2021, medRxiv.

Randomly primed, strand-switching, MinION-based sequencing for the detection and characterization of cultured RNA viruses

D. Stallknecht, S. Tompkins, E. Howerth, 2019, bioRxiv.

Avian Influenza Viruses Infect Primary Human Bronchial Epithelial Cells Unconstrained by Sialic Acid α2,3 Residues

R. Tripp, D. Steinhauer, S. Tompkins, 2011, PloS one.

Replication and pathogenesis associated with H5N1, H5N2, and H5N3 low-pathogenic avian influenza virus infection in chickens and ducks

E. Mundt, R. Tripp, S. Tompkins, 2009, Archives of Virology.

Potential for Low-Pathogenic Avian H7 Influenza A Viruses To Replicate and Cause Disease in a Mammalian Model

R. Webster, D. Stallknecht, Mark Zanin, 2016, Journal of Virology.

Revised model for early memory T-cell protection against respiratory virus challenge

R. Tripp, S. Tompkins, 2008 .

Enhanced generation of influenza-specific tissue resident memory CD8 T cells in NK-depleted mice

S. Tompkins, K. Klonowski, Katie L. Reagin, 2021, Scientific reports.

Polymerase Discordance in Novel Swine Influenza H3N2v Constellations Is Tolerated in Swine but Not Human Respiratory Epithelial Cells

T. Nagy, R. Tripp, S. Tompkins, 2014, PloS one.

Gene silencing in the therapy of influenza and other respiratory diseases: Targeting to RNase P by use of External Guide Sequences (EGS)

R. Fuleihan, D. Dreyfus, L. Ghoda, 2007, Biologics : targets & therapy.

Bat cells from Pteropus alecto are susceptible to influenza A virus infection and reassortment

R. Tripp, S. Tompkins, D. Dlugolenski, 2013, Influenza and other respiratory viruses.

De Novo Central Nervous System Processing of Myelin Antigen Is Required for the Initiation of Experimental Autoimmune Encephalomyelitis1

S. Miller, J. Ting, S. Tompkins, 2002, The Journal of Immunology.

Assessment of the role of determinant selection in genetic control of the immune response to insulin in H-2b mice.

S. Tompkins, P. Jensen, J. Moore, 1999, Journal of immunology.

Interferon Lambda Upregulates IDO1 Expression in Respiratory Epithelial Cells After Influenza Virus Infection.

R. Tripp, S. Tompkins, Jackelyn Crabtree, 2015, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Coated protein nanoclusters from influenza H7N9 HA are highly immunogenic and induce robust protective immunity.

R. Compans, R. Tripp, S. Tompkins, 2017, Nanomedicine : nanotechnology, biology, and medicine.

Erratum to: Serial passage in ducks of a low-pathogenic avian influenza virus isolated from a chicken reveals a high mutation rate in the hemagglutinin that is likely due to selection in the host

E. Mundt, R. Tripp, S. Tompkins, 2015, Archives of Virology.

Serial passage in ducks of a low-pathogenic avian influenza virus isolated from a chicken reveals a high mutation rate in the hemagglutinin that is likely due to selection in the host

E. Mundt, R. Tripp, S. Tompkins, 2015, Archives of Virology.

Subsisting H1N1 influenza memory responses are insufficient to protect from pandemic H1N1 influenza challenge in C57BL/6 mice.

R. Tripp, S. Tompkins, J. Fox, 2013, The Journal of general virology.

Subsisting H 1 N 1 influenza memory responses are insufficient to protect from pandemic H 1 N 1 influenza challenge in C 57 BL / 6 mice

R. Tripp, S. Tompkins, J. Fox, 2013 .

Theiler's Virus‐Mediated Autoimmunity

S. Miller, S. Tompkins, K. Fuller, 2002, Annals of the New York Academy of Sciences.

Encephalomyelitis Initiation of Experimental Autoimmune of Myelin Antigen Is Required for the De Novo Central Nervous System Processing

L. Kaer, J. Ting, S. Tompkins, 2002 .

Developing a platform system for gene delivery: amplifying virus-like particles (AVLP) as an influenza vaccine

S. Stice, P. McCray, S. Tompkins, 2017, npj Vaccines.

highly pathogenic avian influenza virus infection following intranasal or intramuscular

S. Tompkins, B. He, J. Gabbard, 2012 .

Surveillance of feral cats for influenza A virus in North Central Florida

D. Stallknecht, R. Tripp, S. Tompkins, 2011, Influenza and other respiratory viruses.

Efficacy of Parainfluenza Virus 5 (PIV5)-vectored Intranasal COVID-19 Vaccine as a Single Dose Vaccine and as a Booster against SARS-CoV-2 Variants

Linhui Hao, S. Tompkins, B. He, 2022, bioRxiv.

Matrix Protein 2 Extracellular Domain-Specific Monoclonal Antibodies Are an Effective and Potentially Universal Treatment for Influenza A

S. Tompkins, Scott K. Johnson, Lynn Bimler, 2020, Journal of Virology.

A Novel Influenza Virus Hemagglutinin-Respiratory Syncytial Virus (RSV) Fusion Protein Subunit Vaccine against Influenza and RSV

R. Tripp, S. Tompkins, L. Jones, 2013, Journal of Virology.

Protection against lethal influenza virus challenge by RNA interference in vivo.

T. Tumpey, S. Tompkins, C. Lo, 2004, Proceedings of the National Academy of Sciences of the United States of America.

Influenza A Virus Hemagglutinin and Other Pathogen Glycoprotein Interactions with NK Cell Natural Cytotoxicity Receptors NKp46, NKp44, and NKp30

S. Tompkins, J. Luczo, Sydney L. Ronzulli, 2021, Viruses.

Hydrophobic Inactivation of Influenza Viruses Confers Preservation of Viral Structure with Enhanced Immunogenicity

J. Humberd, R. Blumenthal, Mathias Viard, 2008, Journal of Virology.

4’-Fluorouridine mitigates lethal infection with pandemic human and highly pathogenic avian influenza viruses

R. Plemper, Julien Sourimant, A. Kolykhalov, 2022, bioRxiv.

Orally Efficacious Broad-Spectrum Ribonucleoside Analog Inhibitor of Influenza and Respiratory Syncytial Viruses

R. Plemper, A. Kolykhalov, Anice C. Lowen, 2018, Antimicrobial Agents and Chemotherapy.

Targeting Organic Anion Transporter 3 with Probenecid as a Novel Anti-Influenza A Virus Strategy

R. Tripp, S. Tompkins, Olivia Perwitasari, 2012, Antimicrobial Agents and Chemotherapy.

Respiratory syncytial virus modifies microRNAs regulating host genes that affect virus replication

R. Tripp, S. Tompkins, A. Bakre, 2012, The Journal of general virology.

Bordetella bronchiseptica-Mediated Interference Prevents Influenza A Virus Replication in the Murine Nasal Cavity

E. Ghedin, S. Tompkins, J. Luczo, 2023, Microbiology spectrum.

Characterization of an immediate-early gene induced in adherent monocytes that encodes IκB-like activity

S. Haskill, P. Ralph, A. Baldwin, 1991, Cell.

Experimental vaccines against potentially pandemic and highly pathogenic avian influenza viruses.

S. Tompkins, A. Mooney, Alaina J. Mooney, 2013, Future virology.

Therapeutic applications of RNAi for silencing virus replication.

R. Tripp, S. Tompkins, Ralph A Tripp, 2009, Methods in molecular biology.

Swine Influenza Virus PA and Neuraminidase Gene Reassortment into Human H1N1 Influenza Virus Is Associated with an Altered Pathogenic Phenotype Linked to Increased MIP-2 Expression

R. Tripp, S. Tompkins, D. Dlugolenski, 2015, Journal of Virology.

Cold-Adapted Influenza and Recombinant Adenovirus Vaccines Induce Cross-Protective Immunity against pH1N1 Challenge in Mice

Mark R. Soboleski, D. Pérez, Jianqiang Ye, 2011, PloS one.

Comparison of the receptor binding properties of contemporary swine isolates and early human pandemic H1N1 isolates (Novel 2009 H1N1).

David F. Smith, R. Cummings, M. Gramer, 2011, Virology.

A humanized anti-M2 scFv shows protective in vitro activity against influenza.

A. Bradbury, N. Velappan, S. Tompkins, 2009, Protein engineering, design & selection : PEDS.

Randomly primed, strand-switching, MinION-based sequencing for the detection and characterization of cultured RNA viruses

D. Stallknecht, S. Tompkins, E. Howerth, 2020, Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc.

Broadly Reactive Human Monoclonal Antibodies Elicited following Pandemic H1N1 Influenza Virus Exposure Protect Mice against Highly Pathogenic H5N1 Challenge.

J. Wrammert, R. Ahmed, P. Wilson, 2018 .

Genome-wide siRNA Screening at Biosafety Level 4 Reveals a Crucial Role for Fibrillarin in Henipavirus Infection

Cathryn M. Gould, J. Lowenthal, K. Simpson, 2016, PLoS pathogens.

Ferrets as a model for tuberculosis transmission

S. Tompkins, A. Bakre, B. He, 2022, Frontiers in Cellular and Infection Microbiology.

Single-Dose Vaccination of a Recombinant Parainfluenza Virus 5 Expressing NP from H5N1 Virus Provides Broad Immunity against Influenza A Viruses

S. Tompkins, B. He, J. Gabbard, 2013, Journal of Virology.

Recombinant Parainfluenza Virus 5 Expressing Hemagglutinin of Influenza A Virus H5N1 Protected Mice against Lethal Highly Pathogenic Avian Influenza Virus H5N1 Challenge

S. Tompkins, B. He, J. Gabbard, 2012, Journal of Virology.

Matrix Protein 2 Vaccination and Protection against Influenza Viruses, Including Subtype H5N1

T. Tumpey, S. Tompkins, Z. Ye, 2007, Emerging infectious diseases.

Animal models for evaluation of influenza vaccines.

R. Tripp, S. Tompkins, Ralph A. Tripp, 2009, Current topics in microbiology and immunology.

Intranasal powder live attenuated influenza vaccine is thermostable, immunogenic, and protective against homologous challenge in ferrets

N. Petrovsky, S. Tompkins, J. Luczo, 2021, npj Vaccines.

Comparative Pathology in Ferrets Infected with H1N1 Influenza A Viruses Isolated from Different Hosts

T. Nagy, R. Tripp, S. Tompkins, 2011, Journal of Virology.

Antiviral Responses by Swine Primary Bronchoepithelial Cells Are Limited Compared to Human Bronchoepithelial Cells Following Influenza Virus Infection

Ralph A. Tripp, R. Tripp, S. Tompkins, 2013, PloS one.

A europium fluoroimmunoassay for measuring binding of antigen to class II MHC glycoproteins.

S. Tompkins, P. Jensen, J. Moore, 1993, Journal of immunological methods.

Potential directions for chicken immunology research.

C. Stewart, S. Tompkins, A. Keyburn, 2013, Developmental and comparative immunology.

Elizabeth In Vivo and In Vitro Replication Nuclear Export , Reduces Influenza A Virus Verdinexor , a Novel Selective Inhibitor of

E. Baloglu, R. Tripp, S. Tompkins, 2014 .

Recombinant parainfluenza virus 5 (PIV5) expressing the influenza A virus hemagglutinin provides immunity in mice to influenza A virus challenge.

R. Lamb, G. Leser, R. Tripp, 2007, Virology.

Evaluation of a SARS-CoV-2 Capture IgM Antibody Assay in Convalescent Sera

L. Anderson, N. Rouphael, S. Tompkins, 2021, Microbiology spectrum.

A Kmer-based paired-end read de novo assembler and genotyper for canine MHC class I genotyping

Shaying Zhao, W. Hildebrand, S. Tompkins, 2023, iScience.

Targeting Cell Division Cycle 25 Homolog B To Regulate Influenza Virus Replication

A. Torrecilhas, R. Tripp, S. Tompkins, 2013, Journal of Virology.

Targeting Cell Division Cycle 25 Homolog B ( CDC 25 B ) to Regulate Influenza Virus 1 Replication

A. Torrecilhas, R. Tripp, S. Tompkins, 2013 .

Efficacy of a Parainfluenza Virus 5 (PIV5)-Based H7N9 Vaccine in Mice and Guinea Pigs: Antibody Titer towards HA Was Not a Good Indicator for Protection

S. Tompkins, B. He, D. Dlugolenski, 2015, PloS one.

Efficacy of Parainfluenza Virus 5 Mutants Expressing Hemagglutinin from H5N1 Influenza A Virus in Mice

S. Tompkins, B. He, J. Gabbard, 2013, Journal of Virology.

Recombinant Parainfluenza Virus 5 Vaccine Encoding the Influenza Virus Hemagglutinin Protects against H5N1 Highly Pathogenic Avian Influenza Virus Infection following Intranasal or Intramuscular Vaccination of BALB/c Mice

S. Tompkins, B. He, J. Gabbard, 2012, Journal of Virology.

Feline Coronavirus Infection of Domestic Cats Causes Development of Cross-Reactive Antibodies to SARS-CoV-2 Receptor Binding Domain

J. Garrett Morris, B. Sahay, S. Tompkins, 2022, bioRxiv.

M2e-specific monoclonal antibody cocktails against influenza A virus are superior to individual monoclonal antibody treatments, universally effective, and viral escape mutant resistant

S. Tompkins, Scott K. Johnson, Lynn Bimler, 2022, bioRxiv.

Engineering Enhanced Vaccine Cell Lines To Eradicate Vaccine-Preventable Diseases: the Polio End Game

Weilin Wu, R. Tripp, S. Tompkins, 2015, Journal of Virology.

Engineering enhanced vaccine cell lines to eradicate vaccine preventable diseases: the polio endgame (VAC9P.1107)

Weilin Wu, R. Tripp, S. Tompkins, 2015, The Journal of Immunology.

One-step assay for detecting influenza virus using dynamic light scattering and gold nanoparticles.

R. Tripp, S. Tompkins, J. Driskell, 2011, The Analyst.

Clinical validation of innovative, low cost, kit-free, RNA processing protocol for RT-PCR based COVID-19 testing.

A. K. Mondal, N. S. Sahajpal, A. Njau, 2020, medRxiv.

Antiviral agents for influenza virus

R. Tripp, S. Tompkins, Olivia Perwitasari, 2015 .

Characterizing Emerging Canine H3 Influenza Viruses

Gavin J. D. Smith, Guohua Yang, R. Webby, 2020, PLoS pathogens.

Broadly Reactive Human Monoclonal Antibodies Elicited following Pandemic H1N1 Influenza Virus Exposure Protect Mice against Highly Pathogenic H5N1 Challenge

J. Wrammert, R. Ahmed, P. Wilson, 2018, Journal of Virology.

Erratum to: Serial passage in ducks of a low-pathogenic avian influenza virus isolated from a chicken reveals a high mutation rate in the hemagglutinin that is likely due to selection in the host

E. Mundt, R. Tripp, S. Tompkins, 2015, Archives of Virology.

Protection of K18-hACE2 mice and ferrets against SARS-CoV-2 challenge by a single-dose mucosal immunization with a parainfluenza virus 5–based COVID-19 vaccine

D. Meyerholz, Kun Li, P. McCray, 2021, Science Advances.

Avian influenza virus isolates from wild birds replicate and cause disease in a mouse model of infection.

D. Stallknecht, S. Tompkins, E. Driskell, 2010, Virology.

A general computational design strategy for stabilizing viral class I fusion proteins

Eva-Maria Strauch, S. Tompkins, M. F. Criado, 2023, bioRxiv.

Both Feline Coronavirus Serotypes 1 and 2 Infected Domestic Cats Develop Cross-Reactive Antibodies to SARS-CoV-2 Receptor Binding Domain: Its Implication to Pan-CoV Vaccine Development

J. Garrett Morris, B. Sahay, S. Tompkins, 2023, Viruses.

Comparison of Microchip Transponder and Noncontact Infrared Thermometry with Rectal Thermometry in Domestic Swine (Sus scrofa domestica).

S. Tompkins, B. He, Scott K. Johnson, 2016, Journal of the American Association for Laboratory Animal Science : JAALAS.

, Guinea Pig Model Efficient Contact Transmission in the Infectious Dose , High Growth Rate , and Novel H 7 N 9 Influenza Virus Shows Low

T. Kuiken, R. Tripp, D. Steinhauer, 2014 .

Novel H7N9 Influenza Virus Shows Low Infectious Dose, High Growth Rate, and Efficient Contact Transmission in the Guinea Pig Model

T. Kuiken, R. Tripp, D. Steinhauer, 2013, Journal of Virology.

Environmental Stability of Swine and Human Pandemic Influenza Viruses in Water under Variable Conditions of Temperature, Salinity, and pH

D. Stallknecht, S. Tompkins, R. Berghaus, 2016, Applied and Environmental Microbiology.

Developing a platform system for gene delivery: amplifying virus-like particles (AVLP) as an influenza vaccine

S. Stice, P. McCray, S. Tompkins, 2017, npj Vaccines.

MicroRNA Regulation of Human Protease Genes Essential for Influenza Virus Replication

R. Tripp, Victoria A. Meliopoulos, S. Tompkins, 2012, PloS one.

A Low-Dose Triple Antibody Cocktail Against the Ectodomain of the Matrix Protein 2 of Influenza A Is A Universally Effective and Viral Escape Mutant Resistant Therapeutic Agent

S. Tompkins, Scott K. Johnson, Lynn Bimler, 2023, bioRxiv.

Influenza Pathogenesis in Genetically Defined Resistant and Susceptible Murine Strains  

S. Tompkins, Shelly J. Samet, 2017, The Yale journal of biology and medicine.

Gain-of-function experiments on H7N9.

Y. Guan, R. Webster, R. Webby, 2013, Science.

Recombinant vaccines for influenza virus.

R. Tripp, S. Tompkins, Ralph A Tripp, 2008, Current opinion in investigational drugs.

Field Research Is Essential to Counter Virological Threats

A. Casadevall, R. Webby, D. Stallknecht, 2023, Journal of virology.

Influenza Pathogenesis in Genetically Defined Resistant and Susceptible Murine Strains  

S. Tompkins, Shelly J. Samet, 2017, The Yale Journal of Biology and Medicine.

Subsisting H1N1 influenza memory responses are insufficient to protect from pandemic H1N1 influenza challenge in C57BL/6 mice.

R. Tripp, S. Tompkins, J. Fox, 2013, The Journal of general virology.

Mice b Response to Insulin in H-2 Selection in Genetic Control of the Immune Assessment of the Role of Determinant

S. Tompkins, P. Jensen, W. Thayer, 1999 .

H7N9 influenza A virus in turkeys in Minnesota.

D. Stallknecht, S. Enomoto, S. Sreevatsan, 2015, The Journal of general virology.

H 7 N 9 influenza A virus in turkeys in Minnesota

D. Stallknecht, S. Enomoto, S. Sreevatsan, 2015 .